TELA
TELA Bio, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website elabio.com
- Employees(FY) 173
- ISIN US8723811084
Performance
-0.99%
1W
+19.92%
1M
+0.33%
3M
-50.82%
6M
-54.53%
YTD
-37.94%
1Y
Profile
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Technical Analysis of TELA 2024-11-22
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-19 03:05
- 2024-11-07 23:12
Q3 2024 TELA Bio Inc Earnings Call(Yahoo Finance)
- 2024-11-07 13:29
- 2024-11-07 05:20
- 2024-11-07 03:05
TELA Bio Reports Third Quarter 2024 Financial Results(Yahoo Finance)
- 2024-11-05 18:49
What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings(Yahoo Finance)
- 2024-11-01 04:05
- 2024-10-25 09:05
OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc(Yahoo Finance)
- 2024-10-24 04:05
- 2024-10-22 20:07
- 2024-10-22 04:05
- 2024-10-17 04:05
TELA Bio to Announce Third Quarter 2024 Financial Results(Globenewswire)
- 2024-10-01 09:02
Orbimed Advisors LLC Reduces Stake in TELA Bio Inc(Yahoo Finance)
- 2024-08-12 05:20
- 2024-08-12 04:05
- 2024-08-09 04:05
- 2024-07-25 04:05
- 2024-07-22 04:05
TELA Bio to Announce Second Quarter 2024 Financial Results(Globenewswire)
- 2024-06-04 04:05
TELA Bio Appoints Jeffrey Blizard to its Board of Directors(Globenewswire)
- 2024-05-20 04:03
TELA Bio Appoints Greg Firestone as Chief Commercial Officer(Globenewswire)
- 2024-05-12 23:01
- 2024-05-10 04:05
- 2024-05-10 03:51
- 2024-05-09 22:15
- 2024-05-09 04:05
TELA Bio Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-05-02 04:10
- 2024-04-24 19:00
TELA Bio to Announce First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-14 19:00
- 2024-04-07 19:00
- 2024-03-21 21:46
Page 1 of 5
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.